How relevant were the models used to measure the impact of Panton-Valentine leukocidin in human staphylococcal infections?
Schwartzman
W A
WA
Beenhouwer
D O
DO
Schaberg
D R
DR
D000038:Abscess / Q000382:microbiology; D000818:Animals; D001427:Bacterial Toxins / Q000235:genetics / Q000378:metabolism*; D017714:Community-Acquired Infections / Q000382:microbiology; D004195:Disease Models, Animal; D005098:Exotoxins / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007956:Leukocidins / Q000235:genetics / Q000378:metabolism*; D016106:Methicillin Resistance; D051379:Mice; D011817:Rabbits; D018805:Sepsis / Q000382:microbiology; D013203:Staphylococcal Infections / Q000382:microbiology / Q000473:pathology*; D013211:Staphylococcus aureus / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity*; D014774:Virulence
D001427:Bacterial Toxins; D005098:Exotoxins; D007956:Leukocidins; C078284:Panton-Valentine leukocidin